Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jespersen

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Ugeskrift for Laeger|October 5, 2002
[The small blue pills]Christian M Jespersen
Ugeskrift for Laeger|July 6, 1987
[Arterial blood pressure during gestagen treatment]C M Jespersen
Cardiovascular Drugs and Therapy|October 12, 1999
Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trialsC M Jespersen
European Heart Journal|August 1, 1995
Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarctionC M Jespersen
The American Journal of Cardiology|June 20, 1996
Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamilC M Jespersen
Cardiovascular Drugs and Therapy|December 1, 1994
Role of ischemia in postinfarction heart failure: hypothetical considerations based on use of verapamil in the DAVIT II Study. Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen
American Journal of Hypertension|March 1, 1997
Hormone replacement therapy and high blood pressureC M Jespersen
Clinical Cardiology|July 1, 1997
The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarctionC M Jespersen
Ugeskrift for Laeger|December 6, 1982
[Arterial blood pressure during estrogen therapy in the climacteric]C M Jespersen
European Heart Journal|April 1, 1993
The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Ugeskrift for Laeger|October 5, 2002
[The small blue pills]Christian M Jespersen
Ugeskrift for Laeger|July 6, 1987
[Arterial blood pressure during gestagen treatment]C M Jespersen
Cardiovascular Drugs and Therapy|October 12, 1999
Verapamil in acute myocardial infarction. The rationales of the VAMI and DAVIT III trialsC M Jespersen
European Heart Journal|August 1, 1995
Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarctionC M Jespersen
The American Journal of Cardiology|June 20, 1996
Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamilC M Jespersen
Cardiovascular Drugs and Therapy|December 1, 1994
Role of ischemia in postinfarction heart failure: hypothetical considerations based on use of verapamil in the DAVIT II Study. Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen
American Journal of Hypertension|March 1, 1997
Hormone replacement therapy and high blood pressureC M Jespersen
Clinical Cardiology|July 1, 1997
The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarctionC M Jespersen
Ugeskrift for Laeger|December 6, 1982
[Arterial blood pressure during estrogen therapy in the climacteric]C M Jespersen
European Heart Journal|April 1, 1993
The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen
Pageof 12